Isoquercetin
Affiliate link: we may earn a commission at no extra cost to you. Disclosures
Isoquercetin. Highly bioavailable quercetin glycoside.
How it works. Better absorbed than aglycone quercetin.
What the research supports. 1 graded claims. Strongest: Reduces VTE in cancer (moderate).
How much to take. Typical dose: 500–1000 mg.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Vitamin D3 + K2, Zinc, Omega-3.
Common forms. Available as Capsule or softgel, Powder, Sublingual or buccal, Liposomal liquid.
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried Isoquercetin. Anecdotes are not medical advice.
Isoquercetin. Highly bioavailable quercetin glycoside.
What it is
Highly bioavailable quercetin glycoside.
Food sources
Goals
How it works
Better absorbed than aglycone quercetin.
Pathways
- Better absorbed than aglycone quercetin
Effects
- ↓VTE in cancer decreases
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
As an Amazon Associate I earn from qualifying purchases. Look for USP, NSF or Informed Sport seals before you buy.
Side effects & interactions
Common side effects
- GI upset
Medication interactions
Always disclose Isoquercetin use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Vitamin D3 + K2Foundational immune modulation.
- ZincRequired cofactor for innate and adaptive immune function.
- Omega-3Anti-inflammatory cardiovascular synergy.
Common forms
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching Isoquercetin and "Reduces VTE in cancer". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Isoquercetin and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching Isoquercetin and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…